Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential. [PDF]
Farooqi M +3 more
europepmc +1 more source
Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database. [PDF]
Lv B, Han J, Yu Y, Li Y.
europepmc +1 more source
Comparative Effectiveness and Safety of Finasteride and Dutasteride in the Treatment of Benign Prostatic Hyperplasia: A Real-World Retrospective Study. [PDF]
Ratajski J +5 more
europepmc +1 more source
Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. [PDF]
Algharably E, Gundert-Remy U.
europepmc +1 more source
Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data. [PDF]
Yu J +5 more
europepmc +1 more source
Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. [PDF]
Schwartzmann I +9 more
europepmc +1 more source
Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review. [PDF]
Ramos-Rodriguez D +7 more
europepmc +1 more source
Beyond Monotherapy: Targeting the Triad of Insulin Resistance, Hyperandrogenism and Obesity in Polycystic Ovary Syndrome. [PDF]
Shaharyar A +4 more
europepmc +1 more source
Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia. [PDF]
Yuan L +17 more
europepmc +1 more source
Prostogrit mitigates testosterone/estradiol induced prostatic enlargement/remodeling in rat model of benign prostatic hyperplasia and fine-tunes prostatic expression of <i>Adra1a</i> and <i>Il6</i> genes. [PDF]
Balkrishna A +6 more
europepmc +1 more source

